CB1 receptor antagonists: new discoveries leading to new perspectives. [electronic resource]
- Acta physiologica (Oxford, England) May 2012
- 41-60 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1748-1716
10.1111/j.1748-1716.2012.02402.x doi
Anti-Obesity Agents--adverse effects Anxiety Disorders--chemically induced Depressive Disorder--chemically induced Humans Obesity--drug therapy Piperidines--therapeutic use Precision Medicine Pyrazoles--therapeutic use Receptor, Cannabinoid, CB1--antagonists & inhibitors Rimonabant